Otsuka Pharmaceutical Development & Commercialization, Inc.
Clinical trials sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., explained in plain language.
-
New pill aims to quench rare kidney Disorder's thirst for water
Disease control Not yet recruitingThis early-stage trial tests a daily capsule called NDI-5001 in 24 adult men with a rare inherited kidney disease that makes them produce huge amounts of urine and feel constantly thirsty. The main goal is to check the drug's safety and how it affects urine volume and concentrati…
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
Healthy men needed to track how experimental schizophrenia drug leaves the body
Knowledge-focused Not yet recruitingThis early-stage trial will give 8 healthy men a single radioactive-labeled dose of an experimental schizophrenia drug to see how it is absorbed, broken down, and eliminated. Participants must be in good health and have regular bowel movements. The study does not aim to treat any…
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC